glp 1 nederland GLP-1 receptoragonisten lijken risico op obesitas-gerelateerde kankers te verlagen GLP-1 Master - NewFysic

OPRAH JOINS WAVE OF CELEBRITIES WHO REVEALED DRAMATIC WEIGHT LOSS IN 2025 A daily 25 mg pill version of Novo Nordisk's Wegovy, a semaglutide designed to treat obesity, is now approved and available for chronic weight management, offering a non-injectable option for some patients

This includes people taking insulin or sulfonylureas, patients with diabetes, patients on blood pressure medications, patients with kidney disease or dehydration risk, patients with a gallbladder history, patients with significant reflux or gastroparesis symptoms, patients with eating disorder history, and patients who have difficulty meeting protein or fluid needs

Prioritize fiber and water, and incorporate more walking and gentle movement if possible

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study